Medium-Chain Specific Acyl-CoA Dehydrogenase, Mitochondrial (MCAD) Peptide
MCAD
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN936935
Quick Overview for Medium-Chain Specific Acyl-CoA Dehydrogenase, Mitochondrial (MCAD) Peptide (ABIN936935)
Target
Medium-Chain Specific Acyl-CoA Dehydrogenase, Mitochondrial (MCAD)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Peptide Type
- Synthetic
-
Sequence
- ATARKFAREE IIPVAAEYDK TGEYPVPLIR RAWELGLMNT HIPENCGGLG
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ACADM antibody,
Alternative Names: ACADM control peptide, ACADM antibody Blocking Peptide, Anti-ACADM Blocking Peptide, Acyl-Coenzyme A Dehydrogenase C-4 To C-12 Straight Chain Blocking Peptide
-
-
Medium-Chain Specific Acyl-CoA Dehydrogenase, Mitochondrial (MCAD) peptide
MCAD Reactivity: Human Host: Synthetic BP, Imm
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Medium-Chain Specific Acyl-CoA Dehydrogenase, Mitochondrial (MCAD)
-
Background
- ACADM Is the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Clinical phenotypes are associated with ACADM hereditary deficiency.
-
Molecular Weight
- 47 kDa
Target
-
You are here:
